Long Cast Advisers highlighted Cross Country Healthcare (NASDAQ:CCRN) in its fourth-quarter 2025 investor letter as one of its largest purchases. The American healthcare talent management company, specialising in nurse, allied and physician staffing, has a market capitalisation of $318.34 million. Trading at $9.78 per share on 11 March 2026, Cross Country Healthcare holds $99 million in net cash with no debt. The company recently received a $20 million termination payment following a failed $615 million acquisition by AYA, bringing cash to over 40% of its market capitalisation. In Q4 2025, the company generated $237 million in revenue, down 5% sequentially and 24% year-over-year. Hedge fund ownership decreased from 33 to 28 portfolios quarter-over-quarter.

Cross Country Healthcare reported a fourth-quarter loss of $82.9 million, or $2.56 per share. Adjusted losses came to 6 cents per share, missing analysts' expectations of 3 cents earnings per share. The Boca Raton, Florida-based healthcare staffing provider posted revenue of $236.8 million, falling short of the $252.3 million forecast by analysts. For the full year, the company reported a loss of $94.9 million on revenue of $1.05 billion. For the current quarter ending in March, Cross Country expects losses between 4 and 6 cents per share, with revenue ranging from $235 million to $240 million.